Adaptimmune Therapeutics plc American Depositary Shares (ADAP) Profit Margin (2015 - 2025)
Adaptimmune Therapeutics plc American Depositary Shares (ADAP) profit margin from Jun 30, 2015 to Jun 30, 2025. The current Adaptimmune Therapeutics plc American Depositary Shares (ADAP) profit margin is -221.78%. You can export chart.
Annual Profit Margin
Quarterly Profit Margin
Annual Profit Margin change of Adaptimmune Therapeutics plc American Depositary Shares (ADAP)
| Year | Profit Margin | Change |
|---|---|---|
| 2024 | -39.77% | -78.94% |
| 2023 | -188.90% | -69.00% |
| 2022 | -609.43% | -72.09% |
| 2021 | -2183.56% | +5.24% |
| 2020 | -2074.80% | -41.16% |
| 2019 | -3525.96% | +2201.79% |
| 2018 | -153.18% | -17.38% |
| 2017 | -185.41% | -63.22% |
| 2016 | -504.08% | N/A |
Comparison Adaptimmune Therapeutics plc American Depositary Shares (ADAP) profit margin with competitors
Adaptimmune Therapeutics plc American Depositary Shares (ADAP) profit margin is -221.78%.